Deerfield Management Company, L.P. (Series C) Legend Biotech Corp Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
234Shares Held
61MCall Options Held
609KPut Options Held
400K-
Westfield Capital Management CO LP Boston, MA6.92MShares$256 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$212 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$140 Million4.61% of portfolio
-
Braidwell LP Stamford, CT2.54MShares$94 Million5.53% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...